![](https://investorshub.advfn.com/uicon/545192.png?cb=1485887155)
Friday, March 27, 2020 5:45:19 PM
In my opinion, the single most important variable (aside from having patent protected drugs) in determining whether share price shoots to the moon for small pharma companies, is having registered trials that can generate REAL SCIENTIFIC DATA. We are now registered to run a trial to gain some prelim data through the US FDA. Next, we will run NOVOTECH (registered CRO) sponsored COVID trials in Asia and South Korea. Then we will run IPF and chronic cough trials via Novotech.
Can't argue with science
Bright like a diamond is right.
FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM